Kusajili – Clinical trials directory

Result of your search per sponsor: Archer Biosciences

Man
Between 18 years
and 99 years
Archer Biosciences Update Il y a 4 ans

Archer TPI 287-04 : Essai de phase 2 évaluant l’efficacité d’un traitement par TPI 287 chez des patients ayant un cancer de la prostate. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions] A phase II trial of TPI 287 in patients with metastatic prostate cancer who have progressive neoplastic disease following treatment with one prior taxane regimen.

Country France
organs Prostate
Specialty Chimiothérapie

Essai clos aux inclusions

More information